R E Durand
Overview
Explore the profile of R E Durand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
1935
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jankovic B, Aquino-Parsons C, Raleigh J, Stanbridge E, Durand R, Banath J, et al.
Cytometry B Clin Cytom
. 2006 Feb;
70(2):45-55.
PMID: 16456867
Background: Although tumor hypoxia has been associated with a more aggressive phenotype and lower cure rate, there is no consensus as to the method best suited for routine measurement. Binding...
2.
Durand R, Aquino-Parsons C
Acta Oncol
. 2002 Feb;
40(7):862-9.
PMID: 11859987
In the past few years, 'perfusion-limited' hypoxia caused by intermittent decreases in tumour blood flow has received increasing attention. Little effort, however, has gone into characterizing the nature, magnitude or...
3.
Durand R, Aquino-Parsons C
Acta Oncol
. 2002 Feb;
40(8):929-36.
PMID: 11845957
One of the goals of translational cancer research is to understand basic 'phenomena' so that tumour response to therapy can be improved. One such phenomenon is intermittent tumour blood flow....
4.
Durand R
Cancer Metastasis Rev
. 2002 Feb;
20(1-2):57-61.
PMID: 11831648
As the search for improved anti-cancer drugs continues, new paradigms concerning the reasons for clinical failures in common human solid tumours are also evolving. Classical drug resistance is now perhaps...
5.
Bennewith K, Durand R
Br J Cancer
. 2001 Nov;
85(10):1577-84.
PMID: 11720448
The perfusion of human tumour xenografts was manipulated by administration of diltiazem and pentoxifylline, and the extent that observed changes in tumour perfusion altered tumour radiosensitivity was determined. 2 tumour...
6.
Olive P, Durand R, Raleigh J, Luo C, Aquino-Parsons C
Br J Cancer
. 2000 Nov;
83(11):1525-31.
PMID: 11076663
Pimonidazole is finding increasing use in histochemical analyses of hypoxia in tumours. Whether it can identify every hypoxic cell in a tumour, and whether the usual subjective criteria used to...
7.
Olive P, Durand R, Banath J, Johnston P
Methods Cell Biol
. 2000 Nov;
64:235-49.
PMID: 11070842
No abstract available.
8.
9.
Durand R, LePard N
Radiother Oncol
. 2000 Aug;
56(2):245-52.
PMID: 10927145
Background And Purpose: Mitomycin C was one of the first chemotherapeutic agents to be shown to have preferential cytotoxicity toward hypoxic cells in vitro. Consequently, it has been used clinically...
10.
Olive P, Durand R, Jackson S, Le Riche J, Luo C, Ma R, et al.
Acta Oncol
. 1999 Dec;
38(7):839-44.
PMID: 10606413
The comet assay is a single-cell gel electrophoresis technique that measures DNA damage in individual cells. Since radiation produces 3-4 times more DNA damage in well-oxygenated cells compared with hypoxic...